Literature DB >> 2512151

Penicillin tolerance of group A streptococci.

C Betriu, E Campos, C Cabronero, A Fernandez, J J Picazo, A R Noriega.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512151     DOI: 10.1007/bf02185849

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  An epidemic of penicillin-tolerant group A streptococcal pharyngitis in children living in a closed community: mass treatment with erythromycin.

Authors:  R Dagan; M Ferne; M Sheinis; M Alkan; E Katzenelson
Journal:  J Infect Dis       Date:  1987-09       Impact factor: 5.226

2.  Antimicrobial susceptibilities of species of viridans streptococci.

Authors:  A M Bourgault; W R Wilson; J A Washington
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

3.  Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis.

Authors:  T D Smith; W C Huskins; K S Kim; E L Kaplan
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

4.  Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: reevaluation.

Authors:  S Feldman; A L Bisno; L Lott; R Dodge; R E Jackson
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

5.  Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis.

Authors:  K S Kim; E L Kaplan
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

6.  The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms.

Authors:  H EAGLE; A D MUSSELMAN
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

7.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

Authors:  D L Stevens; A E Gibbons; R Bergstrom; V Winn
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

8.  Treatment of Group A streptococcal pharyngitis in children. Results of a prospective, randomized study of four antimicrobial agents.

Authors:  C M Ginsburg; G H McCracken; J B Steinberg; S D Crow; B F Dildy; F Cope; T Zweighaft
Journal:  Clin Pediatr (Phila)       Date:  1982-02       Impact factor: 1.168

9.  Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy.

Authors:  S Chaudhary; S A Bilinsky; J L Hennessy; S M Soler; S E Wallace; C M Schacht; A L Bisno
Journal:  J Pediatr       Date:  1985-03       Impact factor: 4.406

Review 10.  The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.

Authors:  I Brook
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct
  10 in total
  4 in total

1.  Silent spontaneous retroperitoneal abscess caused by M-type 18 Streptococcus pyogenes.

Authors:  J M Llibre; P Puig; A Aloy; J Roset; J Torne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

2.  Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.

Authors:  C Betriu; A Sanchez; M Gomez; A Cruceyra; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 3.  Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis.

Authors:  G J van Asselt; R P Mouton; C P van Boven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

Review 4.  [Patient consent to "antimicrobial treatment of tonsillitis"].

Authors:  C Cenjor; J A García-Rodríguez; A Ramos; J Cervera; M Tomás; F Asensi; J L Cañada; M Gobernado; T Isasiá; C López-Madroñero; M Martínez; F Pérez-Escanilla; J Picazo; J Prieto; T Sampelayo
Journal:  Acta Otorrinolaringol Esp       Date:  2003-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.